Nisa Investment Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
Nisa Investment Advisors's TXG Position: Q1 2026 in Review
Nisa Investment Advisors increased its 10x Genomics (TXG) stake by 105% in Q1 2026, buying an estimated $50.5K and bringing the position to 4,940 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.
Nisa Investment Advisors first reported a position in TXG in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.
- Nisa Investment Advisors held 4,940 shares of 10x Genomics worth $105K as of Q1 2026.
- Nisa Investment Advisors bought 2,526 10x Genomics shares in Q1 2026, an estimated $50.5K.
- 10x Genomics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1403 holding.
- Nisa Investment Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 18 quarters since.
- Nisa Investment Advisors's 10x Genomics position peaked at $1.58M in Q4 2023.
- 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.